Metagenomic Sequencing Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB512244731

Publication Date:

December 3, 2024

Pages:

122

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

Shotgun metagenomic sequencing听allows researchers to comprehensively sample all genes in all organisms present in a given complex sample. The method enables microbiologists to evaluate bacterial diversity and detect the abundance of microbes in various environments.
The global market for Metagenomic Sequencing Service was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for Metagenomic Sequencing Service was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Metagenomic Sequencing Service was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Metagenomic Sequencing Service was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Metagenomic Sequencing Service include Illumina, Thermo Fisher Scientific, QIAGEN NV, PerkinElmer, Oxford Nanopore Technologies Plc, GATC Biotech, Enterome Bioscience, Quest Diagnostics and Roche, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Metagenomic Sequencing Service, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Metagenomic Sequencing Service by region & country, by Type, and by Application.
The Metagenomic Sequencing Service market size, estimations, and forecasts are provided in terms of sales volume (Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Metagenomic Sequencing Service.
Market Segmentation
By Company
Illumina
Thermo Fisher Scientific
QIAGEN NV
PerkinElmer
Oxford Nanopore Technologies Plc
GATC Biotech
Enterome Bioscience
Quest Diagnostics
Roche
CLC Bio
Agilent Technologies
Macrogen
Helicos BioSciences
Segment by Type:
Shotgun Metagenomic Sequencing
16S rRNA Sequencing
Metatranscriptomics
Whole-Genome Sequencing & De Novo Assembly
Segment by Application
Clinical Diagnostic
Gut Microbe Characterization
Drug Discovery
Biofuel
Agriculture
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Metagenomic Sequencing Service manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Metagenomic Sequencing Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Metagenomic Sequencing Service in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Market Overview
1.1 Metagenomic Sequencing Service Product Introduction
1.2 Global Metagenomic Sequencing Service Market Size Forecast
1.2.1 Global Metagenomic Sequencing Service Sales Value (2019-2030)
1.2.2 Global Metagenomic Sequencing Service Sales Volume (2019-2030)
1.2.3 Global Metagenomic Sequencing Service Sales Price (2019-2030)
1.3 Metagenomic Sequencing Service Market Trends & Drivers
1.3.1 Metagenomic Sequencing Service Industry Trends
1.3.2 Metagenomic Sequencing Service Market Drivers & Opportunity
1.3.3 Metagenomic Sequencing Service Market Challenges
1.3.4 Metagenomic Sequencing Service Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Metagenomic Sequencing Service Players Revenue Ranking (2023)
2.2 Global Metagenomic Sequencing Service Revenue by Company (2019-2024)
2.3 Global Metagenomic Sequencing Service Players Sales Volume Ranking (2023)
2.4 Global Metagenomic Sequencing Service Sales Volume by Company Players (2019-2024)
2.5 Global Metagenomic Sequencing Service Average Price by Company (2019-2024)
2.6 Key Manufacturers Metagenomic Sequencing Service Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Metagenomic Sequencing Service Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Metagenomic Sequencing Service
2.9 Metagenomic Sequencing Service Market Competitive Analysis
2.9.1 Metagenomic Sequencing Service Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Metagenomic Sequencing Service Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Metagenomic Sequencing Service as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Shotgun Metagenomic Sequencing
3.1.2 16S rRNA Sequencing
3.1.3 Metatranscriptomics
3.1.4 Whole-Genome Sequencing & De Novo Assembly
3.2 Global Metagenomic Sequencing Service Sales Value by Type
3.2.1 Global Metagenomic Sequencing Service Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Metagenomic Sequencing Service Sales Value, by Type (2019-2030)
3.2.3 Global Metagenomic Sequencing Service Sales Value, by Type (%) (2019-2030)
3.3 Global Metagenomic Sequencing Service Sales Volume by Type
3.3.1 Global Metagenomic Sequencing Service Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Metagenomic Sequencing Service Sales Volume, by Type (2019-2030)
3.3.3 Global Metagenomic Sequencing Service Sales Volume, by Type (%) (2019-2030)
3.4 Global Metagenomic Sequencing Service Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Clinical Diagnostic
4.1.2 Gut Microbe Characterization
4.1.3 Drug Discovery
4.1.4 Biofuel
4.1.5 Agriculture
4.1.6 Others
4.2 Global Metagenomic Sequencing Service Sales Value by Application
4.2.1 Global Metagenomic Sequencing Service Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Metagenomic Sequencing Service Sales Value, by Application (2019-2030)
4.2.3 Global Metagenomic Sequencing Service Sales Value, by Application (%) (2019-2030)
4.3 Global Metagenomic Sequencing Service Sales Volume by Application
4.3.1 Global Metagenomic Sequencing Service Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Metagenomic Sequencing Service Sales Volume, by Application (2019-2030)
4.3.3 Global Metagenomic Sequencing Service Sales Volume, by Application (%) (2019-2030)
4.4 Global Metagenomic Sequencing Service Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Metagenomic Sequencing Service Sales Value by Region
5.1.1 Global Metagenomic Sequencing Service Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Metagenomic Sequencing Service Sales Value by Region (2019-2024)
5.1.3 Global Metagenomic Sequencing Service Sales Value by Region (2025-2030)
5.1.4 Global Metagenomic Sequencing Service Sales Value by Region (%), (2019-2030)
5.2 Global Metagenomic Sequencing Service Sales Volume by Region
5.2.1 Global Metagenomic Sequencing Service Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Metagenomic Sequencing Service Sales Volume by Region (2019-2024)
5.2.3 Global Metagenomic Sequencing Service Sales Volume by Region (2025-2030)
5.2.4 Global Metagenomic Sequencing Service Sales Volume by Region (%), (2019-2030)
5.3 Global Metagenomic Sequencing Service Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Metagenomic Sequencing Service Sales Value, 2019-2030
5.4.2 North America Metagenomic Sequencing Service Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Metagenomic Sequencing Service Sales Value, 2019-2030
5.5.2 Europe Metagenomic Sequencing Service Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Metagenomic Sequencing Service Sales Value, 2019-2030
5.6.2 Asia Pacific Metagenomic Sequencing Service Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Metagenomic Sequencing Service Sales Value, 2019-2030
5.7.2 South America Metagenomic Sequencing Service Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Metagenomic Sequencing Service Sales Value, 2019-2030
5.8.2 Middle East & Africa Metagenomic Sequencing Service Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Metagenomic Sequencing Service Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Metagenomic Sequencing Service Sales Value
6.2.1 Key Countries/Regions Metagenomic Sequencing Service Sales Value, 2019-2030
6.2.2 Key Countries/Regions Metagenomic Sequencing Service Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Metagenomic Sequencing Service Sales Value, 2019-2030
6.3.2 United States Metagenomic Sequencing Service Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Metagenomic Sequencing Service Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Metagenomic Sequencing Service Sales Value, 2019-2030
6.4.2 Europe Metagenomic Sequencing Service Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Metagenomic Sequencing Service Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Metagenomic Sequencing Service Sales Value, 2019-2030
6.5.2 China Metagenomic Sequencing Service Sales Value by Type (%), 2023 VS 2030
6.5.3 China Metagenomic Sequencing Service Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Metagenomic Sequencing Service Sales Value, 2019-2030
6.6.2 Japan Metagenomic Sequencing Service Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Metagenomic Sequencing Service Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Metagenomic Sequencing Service Sales Value, 2019-2030
6.7.2 South Korea Metagenomic Sequencing Service Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Metagenomic Sequencing Service Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Metagenomic Sequencing Service Sales Value, 2019-2030
6.8.2 Southeast Asia Metagenomic Sequencing Service Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Metagenomic Sequencing Service Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Metagenomic Sequencing Service Sales Value, 2019-2030
6.9.2 India Metagenomic Sequencing Service Sales Value by Type (%), 2023 VS 2030
6.9.3 India Metagenomic Sequencing Service Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Illumina
7.1.1 Illumina Company Information
7.1.2 Illumina Introduction and Business Overview
7.1.3 Illumina Metagenomic Sequencing Service Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Illumina Metagenomic Sequencing Service Product Offerings
7.1.5 Illumina Recent Development
7.2 Thermo Fisher Scientific
7.2.1 Thermo Fisher Scientific Company Information
7.2.2 Thermo Fisher Scientific Introduction and Business Overview
7.2.3 Thermo Fisher Scientific Metagenomic Sequencing Service Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Thermo Fisher Scientific Metagenomic Sequencing Service Product Offerings
7.2.5 Thermo Fisher Scientific Recent Development
7.3 QIAGEN NV
7.3.1 QIAGEN NV Company Information
7.3.2 QIAGEN NV Introduction and Business Overview
7.3.3 QIAGEN NV Metagenomic Sequencing Service Sales, Revenue and Gross Margin (2019-2024)
7.3.4 QIAGEN NV Metagenomic Sequencing Service Product Offerings
7.3.5 QIAGEN NV Recent Development
7.4 PerkinElmer
7.4.1 PerkinElmer Company Information
7.4.2 PerkinElmer Introduction and Business Overview
7.4.3 PerkinElmer Metagenomic Sequencing Service Sales, Revenue and Gross Margin (2019-2024)
7.4.4 PerkinElmer Metagenomic Sequencing Service Product Offerings
7.4.5 PerkinElmer Recent Development
7.5 Oxford Nanopore Technologies Plc
7.5.1 Oxford Nanopore Technologies Plc Company Information
7.5.2 Oxford Nanopore Technologies Plc Introduction and Business Overview
7.5.3 Oxford Nanopore Technologies Plc Metagenomic Sequencing Service Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Oxford Nanopore Technologies Plc Metagenomic Sequencing Service Product Offerings
7.5.5 Oxford Nanopore Technologies Plc Recent Development
7.6 GATC Biotech
7.6.1 GATC Biotech Company Information
7.6.2 GATC Biotech Introduction and Business Overview
7.6.3 GATC Biotech Metagenomic Sequencing Service Sales, Revenue and Gross Margin (2019-2024)
7.6.4 GATC Biotech Metagenomic Sequencing Service Product Offerings
7.6.5 GATC Biotech Recent Development
7.7 Enterome Bioscience
7.7.1 Enterome Bioscience Company Information
7.7.2 Enterome Bioscience Introduction and Business Overview
7.7.3 Enterome Bioscience Metagenomic Sequencing Service Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Enterome Bioscience Metagenomic Sequencing Service Product Offerings
7.7.5 Enterome Bioscience Recent Development
7.8 Quest Diagnostics
7.8.1 Quest Diagnostics Company Information
7.8.2 Quest Diagnostics Introduction and Business Overview
7.8.3 Quest Diagnostics Metagenomic Sequencing Service Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Quest Diagnostics Metagenomic Sequencing Service Product Offerings
7.8.5 Quest Diagnostics Recent Development
7.9 Roche
7.9.1 Roche Company Information
7.9.2 Roche Introduction and Business Overview
7.9.3 Roche Metagenomic Sequencing Service Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Roche Metagenomic Sequencing Service Product Offerings
7.9.5 Roche Recent Development
7.10 CLC Bio
7.10.1 CLC Bio Company Information
7.10.2 CLC Bio Introduction and Business Overview
7.10.3 CLC Bio Metagenomic Sequencing Service Sales, Revenue and Gross Margin (2019-2024)
7.10.4 CLC Bio Metagenomic Sequencing Service Product Offerings
7.10.5 CLC Bio Recent Development
7.11 Agilent Technologies
7.11.1 Agilent Technologies Company Information
7.11.2 Agilent Technologies Introduction and Business Overview
7.11.3 Agilent Technologies Metagenomic Sequencing Service Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Agilent Technologies Metagenomic Sequencing Service Product Offerings
7.11.5 Agilent Technologies Recent Development
7.12 Macrogen
7.12.1 Macrogen Company Information
7.12.2 Macrogen Introduction and Business Overview
7.12.3 Macrogen Metagenomic Sequencing Service Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Macrogen Metagenomic Sequencing Service Product Offerings
7.12.5 Macrogen Recent Development
7.13 Helicos BioSciences
7.13.1 Helicos BioSciences Company Information
7.13.2 Helicos BioSciences Introduction and Business Overview
7.13.3 Helicos BioSciences Metagenomic Sequencing Service Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Helicos BioSciences Metagenomic Sequencing Service Product Offerings
7.13.5 Helicos BioSciences Recent Development
8 Industry Chain Analysis
8.1 Metagenomic Sequencing Service Industrial Chain
8.2 Metagenomic Sequencing Service Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Metagenomic Sequencing Service Sales Model
8.5.2 Sales Channel
8.5.3 Metagenomic Sequencing Service Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Illumina
Thermo Fisher Scientific
QIAGEN NV
PerkinElmer
Oxford Nanopore Technologies Plc
GATC Biotech
Enterome Bioscience
Quest Diagnostics
Roche
CLC Bio
Agilent Technologies
Macrogen
Helicos BioSciences

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂